Autosomal dominant optic atrophy is
characterized by visual impairment in early childhood
with moderate to severe loss of visual acuity, temporal optic disc pallor,
color vision deficits and centrocecal scotoma of variable density. Some patients may also develop
extraocular characteristics like deafness, progressive external
ophthalmoplegia, muscle cramps, hyperreflexia and ataxia. The clinical expression of this disorder is variable.
Autosomal dominant optic atrophy canbe caused by OPA1 mutations. Another locus for optic atrophy, OPA2,
has been mapped to chromosome Xp11.4-p11.21, but no gene has been identified to date. Other loci dientified for optic atrophy (but without a known gene) are: OPA3, OPA4, OPA5, OPA6. Optic
atrophy 7 (OPA7) is caused by mutation in the TMEM126A gene.
In addition optic atrophy has been
described as part of the clinical spectrum of 3-methylglutaconic aciduria, type
I (AUH gene mutation), combined oxidative phosphorylation deficiency 7
(C12orf65 gene mutation), Wolfram syndrome (WFS1 and CISD2 mutations),
mitochondrial complex I deficiency (optic neuropathy, NDUFS1 gene mutation),
mitochondrial DNA depletion syndrome (POLG mutations), SPG7 (SPG7 gene mutations) and
deafness-dystonia-optic atrophy syndrome (TIMM8A gene mutation).